Ethyl Acetate

Ethyl Acetate

SCHEMBL6715165

CCOC(C)=O.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.82
▸ LMNA P02545 1/20 0.82
▸ HSD17B10 Q99714 1/20 0.82
▸ TSHR P16473 2/20 0.50
▸ GAA P10253 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MGAM O43451 1/20 0.46
▸ SI P14410 1/20 0.46
▸ MGAM2 Q2M2H8 1/20 0.46
▸ SOAT1 P35610 1/20 0.46
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ HCAR2 Q8TDS4 1/20 0.42
▸ PIN1 Q13526 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL9454498 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL9663999 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7455458 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL10416485 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL10794928 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7565398 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL11511384 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL8935437 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL10414106 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL8422687 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 — — US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 — — US disclosed
EP-0678520-B1 PROCESS FOR PRODUCING 3-SUBSTITUTED CEPHEM COMPOUND OTSUKA KAGAKU KK (JP) 2001-05-30 — — EP disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 — — EP disclosed
US-5656755-A REACTING AN ALLENYL-B-LACTAM COMPOUND WITH AN ORGANOHALOGEN COMPOUND OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-08-12 — — US disclosed
US-5604217-A CEPHALOSPORIN ANTIBIOTICS EISAI CO., LTD. (JP) 1997-02-18 — — US disclosed
EP-0678520-A1 PROCESS FOR PRODUCING 3-SUBSTITUTED CEPHEM COMPOUND OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1995-10-25 — — EP disclosed
EP-0209751-B1 CEPHALOSPORIN DERIVATIVES AND BACTERICIDES CONTAINING THE SAME MEIJI SEIKA KAISHA LTD. (JP) 1992-09-16 — — EP disclosed
US-4758557-A Cephalosporin derivatives and bactericides containing the same MEIJI SEIKA KAISHA, LTD. (JP) 1988-07-19 — — US disclosed
EP-0209751-A2 Cephalosporin derivatives and bactericides containing the same MEIJI SEIKA KAISHA LTD. (JP) 1987-01-28 — — EP disclosed
EP-0019475-A2 Process for preparing adjacently disubstituted ketones, novel prostaglandins E1 and anti-thrombotic compositions containing them TEIJIN LIMITED (JP) 1980-11-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 ALDH1A1 3508/4885LMNA 4239/4885HSD17B10 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback